Kidney Transplant Recipients clinical trials

Explore recruiting kidney transplant recipients clinical trials.

Recruiting kidney transplant recipients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Transplant Recipients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SAFETY AND EFFICACY OF A 10-DAY COURSE OF REMDESIVIR TO PREVENT SEVERE COVID-19 IN ASYMPTOMATIC OR PAUCISYMPTOMATIC SARS-COV-2-POSITIVE KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-ARM PROOF-OF-CONCEPT INTERVENTIONAL TRIAL

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized controlled trial evaluating the impact of mineralocorticoid receptor blockade by eplerenone on echocardiographic abnormalities among kidney graft recipient under calcineurin inhibitors. KT-CANOPY: Cardiac improvement by eplerenone among patients under cyclosporine or tacrolimus for kidney transplantation.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

SGL-TX-GFR SGLT2i safety and efficacy on kidney allograft function in non-diabetic kidney transplant recipients: A randomized, double-blind, placebo controlled, national, multicenter trial.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

SGL-TX-PTDM: SGLT2i effect on PTDM development and kidney allograft function in kidney transplant recipients: A randomized, double-blind, placebo controlled, national multicenter trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and Safety Clinical Trial for Immune-Guided Prevention of CMV Infection in Low-Risk Kidney Transplantation. (INMUNOVIR Study)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute effects of SGLT2 inhibitor on kidney allograft oxygen tension: A randomized, double-blind, placebo controlled crossover trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Kidney Transplant Recipients trials by city

Kidney Transplant Recipients in Toronto Kidney Transplant Recipients in Vancouver Kidney Transplant Recipients in Montreal Kidney Transplant Recipients in Calgary Kidney Transplant Recipients in Edmonton Kidney Transplant Recipients in Ottawa Kidney Transplant Recipients in Winnipeg Kidney Transplant Recipients in Quebec City Kidney Transplant Recipients in Hamilton Kidney Transplant Recipients in Kitchener Kidney Transplant Recipients in London Kidney Transplant Recipients in Halifax Kidney Transplant Recipients in New York Kidney Transplant Recipients in Los Angeles Kidney Transplant Recipients in Chicago Kidney Transplant Recipients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease